SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants.

MLA

Im, Keon-Il, et al. “SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants.” International Journal of Molecular Sciences, vol. 25, no. 19, Oct. 2024, p. 10512. EBSCOhost, https://doi.org/10.3390/ijms251910512.

APA

Im, K.-I., Kim, N., Lee, J., Oh, U.-H., Lee, H.-W., Lee, D.-G., Min, G.-J., Lee, R., Lee, J., Kim, S., & Cho, S.-G. (2024). SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. International Journal of Molecular Sciences, 25(19), 10512. https://doi.org/10.3390/ijms251910512

Chicago

Im, Keon-Il, Nayoun Kim, Junseok Lee, Ui-Hyeon Oh, Hye-Won Lee, Dong-Gun Lee, Gi-June Min, et al. 2024. “SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants.” International Journal of Molecular Sciences 25 (19): 10512. doi:10.3390/ijms251910512.